Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William Matsui

Showing results (81-90 of 101) with videos related to

Pageof 11
Sort By:
Cancer Biology & Therapy|July 20, 2011
Cyclin-dependent kinase inhibitor Dinaciclib (SCH727965) inhibits pancreatic cancer growth and progression in murine xenograft modelsGeorg Feldmann, Anjali Mishra, Savita Bisht, et al.
Blood|February 4, 2009
Circulating clonotypic B cells in classic Hodgkin lymphomaRichard J Jones, Christopher D Gocke, Yvette L Kasamon, et al.
Cell Stem Cell|September 1, 2010
Tumor-initiating cells are rare in many human tumorsKota Ishizawa, Zeshaan A Rasheed, Robert Karisch, et al.
Leukemia & Lymphoma|July 16, 2011
High-dose cyclophosphamide and rituximab without stem cell transplant: a feasibility study for low grade B-cell, transformed and mantle cell lymphomasDouglas E Gladstone, Javier Bolaños-Meade, Carol Ann Huff, et al.
Science Translational Medicine|June 12, 2015
Integration of Hedgehog and mutant FLT3 signaling in myeloid leukemiaYiting Lim, Lukasz Gondek, Li Li, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 17, 2017
Allogeneic Blood or Marrow Transplantation with Post-Transplantation Cyclophosphamide as Graft-versus-Host Disease Prophylaxis in Multiple MyelomaNilanjan Ghosh, Xiaobu Ye, Hua-Ling Tsai, et al.
Journal of the National Cancer Institute|February 19, 2010
Prognostic significance of tumorigenic cells with mesenchymal features in pancreatic adenocarcinomaZeshaan A Rasheed, Jie Yang, Qiuju Wang, et al.
Science Translational Medicine|May 22, 2015
Adoptive transfer of activated marrow-infiltrating lymphocytes induces measurable antitumor immunity in the bone marrow in multiple myelomaKimberly A Noonan, Carol A Huff, Janice Davis, et al.
Blood|February 4, 2010
High-dose cyclophosphamide as single-agent, short-course prophylaxis of graft-versus-host diseaseLeo Luznik, Javier Bolaños-Meade, Marianna Zahurak, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 25, 2007
Induction of autologous graft-versus-host disease: results of a randomized prospective clinical trial in patients with poor risk lymphomaJavier Bolaños-Meade, Elizabeth Garrett-Mayer, Leo Luznik, et al.
Pageof 11

Showing results (81-90 of 101) with videos related to

Sort By:
Pageof 11
Cancer Biology & Therapy|July 20, 2011
Cyclin-dependent kinase inhibitor Dinaciclib (SCH727965) inhibits pancreatic cancer growth and progression in murine xenograft modelsGeorg Feldmann, Anjali Mishra, Savita Bisht, et al.
Blood|February 4, 2009
Circulating clonotypic B cells in classic Hodgkin lymphomaRichard J Jones, Christopher D Gocke, Yvette L Kasamon, et al.
Cell Stem Cell|September 1, 2010
Tumor-initiating cells are rare in many human tumorsKota Ishizawa, Zeshaan A Rasheed, Robert Karisch, et al.
Leukemia & Lymphoma|July 16, 2011
High-dose cyclophosphamide and rituximab without stem cell transplant: a feasibility study for low grade B-cell, transformed and mantle cell lymphomasDouglas E Gladstone, Javier Bolaños-Meade, Carol Ann Huff, et al.
Science Translational Medicine|June 12, 2015
Integration of Hedgehog and mutant FLT3 signaling in myeloid leukemiaYiting Lim, Lukasz Gondek, Li Li, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 17, 2017
Allogeneic Blood or Marrow Transplantation with Post-Transplantation Cyclophosphamide as Graft-versus-Host Disease Prophylaxis in Multiple MyelomaNilanjan Ghosh, Xiaobu Ye, Hua-Ling Tsai, et al.
Journal of the National Cancer Institute|February 19, 2010
Prognostic significance of tumorigenic cells with mesenchymal features in pancreatic adenocarcinomaZeshaan A Rasheed, Jie Yang, Qiuju Wang, et al.
Science Translational Medicine|May 22, 2015
Adoptive transfer of activated marrow-infiltrating lymphocytes induces measurable antitumor immunity in the bone marrow in multiple myelomaKimberly A Noonan, Carol A Huff, Janice Davis, et al.
Blood|February 4, 2010
High-dose cyclophosphamide as single-agent, short-course prophylaxis of graft-versus-host diseaseLeo Luznik, Javier Bolaños-Meade, Marianna Zahurak, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 25, 2007
Induction of autologous graft-versus-host disease: results of a randomized prospective clinical trial in patients with poor risk lymphomaJavier Bolaños-Meade, Elizabeth Garrett-Mayer, Leo Luznik, et al.
Pageof 11